Search research articles

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A guide to plant breeding for animal breeders.

G3 (Bethesda, Md.)·2026

Same author

Correction: A functional regulatory variant of MYH3 influences muscle fiber-type composition and intramuscular fat content in pigs.

PLoS genetics·2025

Same author

Evaluation of deep learning for predicting rice traits using structural and single-nucleotide genomic variants.

Plant methods·2024

Same author

On the holobiont 'predictome' of immunocompetence in pigs.

Genetics, selection, evolution : GSE·2023

Same author

Eye-LRCN: A Long-Term Recurrent Convolutional Network for Eye Blink Completeness Detection.

IEEE transactions on neural networks and learning systems·2022

Same author

Transposable element polymorphisms improve prediction of complex agronomic traits in rice.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Disease liability prediction from large scale genotyping data using classifiers with a reject option.

José R Quevedo¹, Antonio Bahamonde, Miguel Pérez-Enciso

¹Oviedo University, Gijón.

IEEE/ACM Transactions on Computational Biology and Bioinformatics

|March 9, 2011

Summary

This summary is machine-generated.

This study introduces a new method for predicting common disease risk using genome-wide genetic data. Classifiers with a reject option improve prediction accuracy by avoiding uncertain classifications.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Jun 3, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Area of Science:

Genetics
Bioinformatics
Computational Biology

Background:

Genome-wide association studies (GWA) identify genetic polymorphisms linked to phenotypic variations.
Significant genetic variants often have limited predictive power for common disease development.

Purpose of the Study:

To develop and evaluate a method for predicting disease risk using genome-wide genotypic data.
To enhance prediction reliability by employing classifiers with a reject option.

Main Methods:

Utilized genome-wide genotypic data for disease risk prediction.
Implemented classifiers with a reject option to manage prediction uncertainty.
Tested the approach on the Wellcome Trust Case Control Consortium (WTCCC) dataset.

Main Results:

The proposed method aims to improve the accuracy of disease risk prediction.
Classifiers with a reject option selectively make predictions when confidence is high.
The WTCCC dataset provided a robust test case with 14,000 disease cases and 3,000 controls.

Conclusions:

Classifiers with a reject option offer a reliable approach for predicting disease risk from genetic data.
This method addresses the challenge of limited predictive power from individual genetic variants.
Further validation on diverse datasets is warranted to confirm generalizability.